0001415889-16-005891.txt : 20160513 0001415889-16-005891.hdr.sgml : 20160513 20160513172506 ACCESSION NUMBER: 0001415889-16-005891 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160419 FILED AS OF DATE: 20160513 DATE AS OF CHANGE: 20160513 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medovex Corp. CENTRAL INDEX KEY: 0001591165 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3729 HARDEE AVENUE CITY: ATLANTA STATE: GA ZIP: 30341 BUSINESS PHONE: (404) 393-6989 MAIL ADDRESS: STREET 1: 3729 HARDEE AVENUE CITY: ATLANTA STATE: GA ZIP: 30341 FORMER COMPANY: FORMER CONFORMED NAME: SpineZ DATE OF NAME CHANGE: 20131105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gorlin Jarrett S CENTRAL INDEX KEY: 0001629409 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36763 FILM NUMBER: 161649647 MAIL ADDRESS: STREET 1: 3279 HERDEE AVE CITY: ATLANTA STATE: GA ZIP: 30341 4/A 1 form4a-05132016_020555.xml X0306 4/A 2016-04-19 2016-04-21 0001591165 Medovex Corp. MDVX 0001629409 Gorlin Jarrett S 3279 HARDEE AVENUE ATLANTA GA 30341 true true false false CHIEF EXECUTIVE OFFICER Common Stock 2016-04-19 4 P 0 43028 1.255 A 560065 D Warrant to purchase shares of Common Stock 1.30 2016-04-19 4 P 0 21514 0 A 2016-10-19 2021-04-19 Common Stock 21514 62314 D On April 21, 2016, the Reporting Person filed a Form 4 with the Commission. The previously filed Form 4 reported the purchase of shares of common stock (the "Shares") of MedoveX Corporation (the "Company"). In compliance with NASDAQ rules and regulations, the Reporting Person is hereby amending his report to accurately reflect the correct number of Shares purchased which was reduced, effectively increasing the purchase price from $1.225 to $1.255. Represents shares held by The Jarrett S. & Rebecca L. Gorlin Family Limited Partnership. Mr. Gorlin disclaims beneficial ownership of these shares. The Warrant is initially exercisable six months following the date of issuance (04/19/2016) for a period of five (5) years from the date of issuance On April 21, 2016, the Reporting Person filed a Form 4 with the Commission. The previously filed Form 4 reported the purchase of a warrant to purchase shares of common stock (the "Warrant") of MedoveX Corporation (the "Company"). In compliance with NASDAQ rules and regulations, the Reporting Person is hereby amending his report to accurately reflect the correct number of underlying shares that the Warrant represents, which was reduced pursuant to NASDAQ guidelines. /s/ Jarrett Gorlin 2016-05-13